Graphic

Reauthorize the Prescription Drug User Fee Act

PhRMA July 12, 2017

Reauthorization of the Prescription Drug, Biosimilar and Generic Drug User Fee Acts is crucial to ensuring innovative new medicines continue to reach patients in need.

Download